Navidea Biopharmaceuticals (NYSE:NAVB) Now Covered by Analysts at StockNews.com
Analysts at StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research note issued on Friday. The firm set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE NAVB opened at $0.00 on Friday. Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month […]
Analysts at StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research note issued on Friday. The firm set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE NAVB opened at $0.00 on Friday. Navidea Biopharmaceuticals has a twelve month low of $0.00 and a twelve month […]
